Cargando...
Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group
Abstract Background Treatments are often unavailable for rare disease patients, especially in low-and-middle-income countries. Reasons for this include lack of financial support for therapies and onerous regulatory requirements for approval of drugs. Other barriers include lack of reimbursement, adm...
Guardado en:
| Publicado en: | Orphanet Journal of Rare Diseases |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artículo |
| Publicado: |
BMC
2021-07-01
|
| Acceso en línea: | https://doi.org/10.1186/s13023-021-01923-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|